1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema
(
- Contribution to journal › Article
- 2018
-
Mark
Deposition of inhaled nanoparticles is reduced in subjects with COPD and correlates with the extent of emphysema : Proof of concept for a novel diagnostic technique
(
- Contribution to journal › Article
-
Mark
Lung function and CT lung densitometry in 37-to 39-year-old individuals with alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Airspace Dimension Assessment with nanoparticles reflects lung density as quantified by MRI
(
- Contribution to journal › Article
- 2017
-
Mark
Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
(
- Contribution to journal › Article
- 2016
-
Mark
T1 Relaxation Time in Lungs of Asymptomatic Smokers.
(
- Contribution to journal › Article
-
Mark
Recovery of inhaled nanoparticles, airflow obstruction and emphysema
2016) European Respiratory Society (ERS) Congress 2016(
- Contribution to conference › Abstract
- 2015
-
Mark
Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
(
- Contribution to journal › Article
-
Mark
Using nanoparticles to detect emphysema
2015) European respiratory society international congress 2015(
- Contribution to conference › Abstract
-
Mark
Exhaled nanoparticles to detect emphysema
2015) The Fleischner Society annual meeting 2015(
- Contribution to conference › Abstract